Cite
MLA Citation
Stefan Groeneweg et al.. “Effectiveness and safety of the tri-iodothyronine analogue Triac in children and adults with MCT8 deficiency: an international, single-arm, open-label, phase 2 trial.” Lancet, vol. 7, no. 9, 2019, pp. 695–706. http://access.bl.uk/ark:/81055/vdc_100089677278.0x000009